162 related articles for article (PubMed ID: 32227043)
1. Unexplored features of Ru(ii) polypyridyl complexes - towards combined cytotoxic and antimetastatic activity.
Gurgul I; Mazuryk O; Łomzik M; Gros PC; Rutkowska-Zbik D; Brindell M
Metallomics; 2020 May; 12(5):784-793. PubMed ID: 32227043
[TBL] [Abstract][Full Text] [Related]
2. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Notaro A; Gasser G
Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
[TBL] [Abstract][Full Text] [Related]
3. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
Fayad C; Audi H; Khnayzer RS; Daher CF
J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
[TBL] [Abstract][Full Text] [Related]
4. The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
Mazuryk O; Suzenet F; Kieda C; Brindell M
Metallomics; 2015 Mar; 7(3):553-66. PubMed ID: 25711770
[TBL] [Abstract][Full Text] [Related]
5. Moving Ru polypyridyl complexes beyond cytotoxic activity towards metastasis inhibition.
Brindell M; Gurgul I; Janczy-Cempa E; Gajda-Morszewski P; Mazuryk O
J Inorg Biochem; 2022 Jan; 226():111652. PubMed ID: 34741931
[TBL] [Abstract][Full Text] [Related]
6. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
[TBL] [Abstract][Full Text] [Related]
7. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
[TBL] [Abstract][Full Text] [Related]
8. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional ruthenium(ii) polypyridyl complexes of curcumin as potential anticancer agents.
Li S; Xu G; Zhu Y; Zhao J; Gou S
Dalton Trans; 2020 Jul; 49(27):9454-9463. PubMed ID: 32598409
[TBL] [Abstract][Full Text] [Related]
10. New ruthenium compounds bearing semicarbazone 2-formylopyridine moiety: Playing with auxiliary ligands for tuning the mechanism of biological activity.
Łomzik M; Mazuryk O; Rutkowska-Zbik D; Stochel G; Gros PC; Brindell M
J Inorg Biochem; 2017 Oct; 175():80-91. PubMed ID: 28738277
[TBL] [Abstract][Full Text] [Related]
11. In vitro cytotoxicity, cellular uptake, reactive oxygen species and cell cycle arrest studies of novel ruthenium(II) polypyridyl complexes towards A549 lung cancer cell line.
Qasim Warraich M; Ghion A; Perdisatt L; O'Neill L; Casey A; O'Connor C
Drug Chem Toxicol; 2021 May; 44(3):319-329. PubMed ID: 30991856
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Matrix Metalloproteinases and Cancer Cell Detachment by Ru(II) Polypyridyl Complexes Containing 4,7-Diphenyl-1,10-phenanthroline Ligands-New Candidates for Antimetastatic Agents.
Gajda-Morszewski P; Gurgul I; Janczy-Cempa E; Mazuryk O; Łomzik M; Brindell M
Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681238
[TBL] [Abstract][Full Text] [Related]
14. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and anticancer properties of new ruthenium polypyridyl complexes with different lipophilicities.
Florence Tikum A; Jeon YJ; Lee JH; Park MH; Bae IY; Kim SH; Lee HJ; Kim J
J Inorg Biochem; 2018 Mar; 180():204-210. PubMed ID: 29329027
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Metastasis by Polypyridyl Ru(II) Complexes through Modification of Cancer Cell Adhesion -
Gurgul I; Janczy-Cempa E; Mazuryk O; Lekka M; Łomzik M; Suzenet F; Gros PC; Brindell M
J Med Chem; 2022 Aug; 65(15):10459-10470. PubMed ID: 35895090
[TBL] [Abstract][Full Text] [Related]
17. Water-soluble amphiphilic ruthenium(ii) polypyridyl complexes as potential light-activated therapeutic agents.
Estalayo-Adrián S; Blasco S; Bright SA; McManus GJ; Orellana G; Williams DC; Kelly JM; Gunnlaugsson T
Chem Commun (Camb); 2020 Aug; 56(65):9332-9335. PubMed ID: 32671364
[TBL] [Abstract][Full Text] [Related]
18. Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.
Li A; Turro C; Kodanko JJ
Acc Chem Res; 2018 Jun; 51(6):1415-1421. PubMed ID: 29870227
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
